Home News

Financial Results Nine month period 2019 - Video

Javier López-Belmonte, Vicepresident and CFO of Laboratorios Farmacéuticos ROVI presents the financial results for the first nine months of 2019.

Mon, 25/11/2019 - 11:12 0 min
Download related document
No votes yet
 
Related
ROVI achieves a 10% increase in operating income and 55% in net profit
ROVI achieves a 10% increase in operating income and 55% in net profit
Laboratorios Farmacéuticos Rovi, SA (BME: ROVI), company Pan-European pharmaceutical company specialized and dedicated to the research,...
5 min
24/02/2021
ROVI completes the manufacture of the first batches of Moderna vaccine
0 min
13/01/2021
ROVI completes the manufacture of the first batches of Moderna vaccine for EU
Laboratorios Farmacéuticos Rovi, S.A. (BME -Spanish Stock Exchanges and Markets: ROVI), a pan-European specialised company engaged in the...
2 min
13/01/2021